MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico
MindScape Retreat in Cozumel, Mexico has released a groundbreaking case study showing a 70% average improvement in Parkinson’s symptoms following a 14-day ibogaine therapy program. Among 30 patients, 52% symptom relief was seen by Day 4, with further gains by Day 14. A quarter of participants who continued microdosing post-retreat maintained or improved results. The therapy, using Ibogaine HCl and TA, showed strong safety and potential neuroregenerative benefits via GDNF activation. - May 02, 2025
MindScape Retreat in Cozumel, Mexico, Offers Innovative Ibogaine Therapy to Address Long-Term SSRI Effects and Serotonin Syndrome Risks
MindScape Retreat in Cozumel, Mexico, offers medically supervised ibogaine treatment to help individuals safely discontinue SSRIs and address associated long-term effects, including the risk of serotonin syndrome. By promoting neuroplasticity and restoring neurotransmitter balance, ibogaine therapy at an Ibogaine Retreat called MindScape Retreat provides a holistic approach to mental health recovery in a serene and supportive environment. - April 25, 2025